Ready to Jump After Recent Trade: Nu Skin Enterprises, Inc. (NUS)

With 0.9 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.79 million shares. During the session, the Household & Personal Products company that operates in wider Consumer Defensive sector, reached to the highest price of $13.81 whereas the lowest price it dropped to was $13.305. The 52-week range on NUS shows that it touched its highest point at $37.78 and its lowest point at $11.73 during that stretch. It currently has a 1-year price target of $12.83. With its current market cap of 667.66 million, NUS has annualized dividend of $1.23 while the current yield stands at 9.10%. Beta for the stock currently stands at 1.15.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NUS was up-trending over the past week, with a rise of 10.74%, but this was up by 12.12% over a month. Three-month performance dropped to -27.83% while six-month performance fell -18.61%. The stock lost -64.05% in the past year, while it has lost -30.43% so far this year. A look at the trailing 12-month EPS for NUS yields -0.07 with Next year EPS estimates of 1.48. For the next quarter, that number is 0.17. This implies an EPS growth rate of -40.42% for this year and 34.32% for next year. EPS is expected to grow by 6.81% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -39.68%.

Float and Shares Shorts:

At present, 49.50 million NUS shares are outstanding with a float of 48.73 million shares on hand for trading. On 2024-04-30, short shares totaled 1.58 million, which was 318.0 higher than short shares on 1711584000. In addition to Mr. Steven J. Lund as the firm’s Co-Founder & Executive Chairman of the Board, Mr. Ryan S. Napierski serves as its President, CEO & Director.

Institutional Ownership:

Through their ownership of 0.85219 of NUS’s outstanding shares, institutional investors have minority control over the company.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-03-31, NUS reported revenue of $417306000.0 and operating income of $15956000.0. The EBITDA in the recently reported quarter was $33997000.0 and diluted EPS was -$0.01.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NUS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.